Start Date
January 31, 2012
Primary Completion Date
August 31, 2013
Study Completion Date
BKM120
100 MG PO QD in cycles of 28 days
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Massachusetts General Hospital
OTHER